Related Experiment Videos

Adenovirus infection of primary malignant lymphoid cells

Roger K Strair1, Wendy Sheay, Lauri Goodell

  • 1The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick 08901, USA. strairrk@umdnj.edu

Leukemia & Lymphoma
|March 23, 2002
PubMed

Insights

Adenoviruses can kill cancer cells, including those in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Specific adenovirus mutants show enhanced cancer cell killing, offering potential new therapies for lymphoid malignancies.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Adenovirus infection induces host cell apoptosis, a barrier to viral replication.
  • Viral proteins interact with cellular pathways regulating cell cycle, transcription, and apoptosis.
  • These cellular mechanisms are also implicated in oncogenesis.

Purpose of the Study:

  • To investigate the use of adenoviruses and their mutants to study regulatory pathways in malignant cells.
  • To explore adenovirus-mediated cytotoxicity in specific lymphoid malignancies.
  • To assess the potential of attenuated adenoviruses as targeted cancer therapeutics.

Main Methods:

  • Infection of chronic lymphocytic leukemia (CLL) cells, mantle cell lymphoma (MCL) cells, and multiple myeloma cell lines with adenoviruses.
  • Utilizing specific adenovirus mutants with enhanced cytotoxicity.
  • Analyzing adenovirus-mediated cell death mechanisms and host cell pathway status.

Main Results:

  • Adenoviruses induce cytotoxicity in CLL, MCL, and multiple myeloma cells.
  • Certain adenovirus mutants exhibit enhanced cytotoxicity.
  • Apoptosis is not always the primary mechanism of cell death induced by these mutants.

Conclusions:

  • Adenovirus-mediated cytotoxicity provides insights into regulatory pathway status in patient-derived malignant cells.
  • Specific attenuated adenoviruses demonstrate potential as targeted therapeutic agents for lymphoid malignancies.
  • Further research can leverage adenovirus-host interactions for novel cancer therapies.

Related Concept Videos